Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma.
Nagai T, Arao T, Furuta K, Sakai K, Kudo K, Kaneda H, Tamura D, Aomatsu K, Kimura H, Fujita Y, Matsumoto K, Saijo N, Kudo M, Nishio K.
Nagai T, et al. Among authors: kudo m, kudo k.
Mol Cancer Ther. 2011 Jan;10(1):169-77. doi: 10.1158/1535-7163.MCT-10-0544.
Mol Cancer Ther. 2011.
PMID: 21220499